MARK SHEPTOFF FINANCIAL PLANNING, LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 147 filers reported holding ANI PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 10.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARK SHEPTOFF FINANCIAL PLANNING, LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$251,000
-18.5%
3,450
-8.0%
0.17%
-19.5%
Q2 2019$308,000
+16.2%
3,7500.0%0.21%
+9.9%
Q1 2019$265,000
+56.8%
3,7500.0%0.19%
+36.4%
Q4 2018$169,000
-26.2%
3,750
-7.4%
0.14%
-10.8%
Q3 2018$229,000
-15.5%
4,0500.0%0.16%
-21.5%
Q2 2018$271,000
+14.8%
4,0500.0%0.20%
+22.0%
Q1 2018$236,000
-9.6%
4,0500.0%0.16%
-3.5%
Q4 2017$261,000
-5.4%
4,050
-22.9%
0.17%
-8.1%
Q3 2017$276,000
+6.2%
5,250
-5.4%
0.18%
+3.4%
Q2 2017$260,000
+4.0%
5,550
+9.9%
0.18%
+0.6%
Q1 2017$250,000
+7.3%
5,050
+31.2%
0.18%
+2.9%
Q4 2016$233,000
-11.1%
3,850
-2.5%
0.17%
-11.3%
Q3 2016$262,000
+19.1%
3,9500.0%0.20%
+18.9%
Q2 2016$220,000
+65.4%
3,9500.0%0.16%
+51.9%
Q1 2016$133,000
-30.7%
3,950
-7.1%
0.11%
-30.8%
Q4 2015$192,000
+57.4%
4,250
+37.1%
0.16%
+45.8%
Q3 2015$122,000
-27.4%
3,100
+14.8%
0.11%
-21.3%
Q2 2015$168,000
+28.2%
2,700
+28.6%
0.14%
+24.8%
Q1 2015$131,000
+11.0%
2,1000.0%0.11%
+4.8%
Q4 2014$118,0002,1000.10%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders